4
Changes in Ownership
Zentalis Pharmaceuticals, Inc. Filed Acc 0000902664-25-005288
10% owner sold 7,500,000 shares at $1.33 ($9,975,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Matrix Capital Management Company, LP 10% owner | 2025-12-15 | Sale | −7,500,000 | $1.33 | $9,975,000 | 6,459,973 | I |
| Open-market sales · 7,500,000 sh · avg $1.33 · $9,975,000 | |||||||
Loading xslF345X05/ownership.xml…